Norstella is driven by its mission: Helping patients gain access to life-saving therapies by transforming the drug development journey. Norstella is working to fulfill this mission in a challenging landscape for pharmaceutical, medtech, and clinical research organizations.
With this as the context, Norstella recently held a recent roundtable discussion in London featuring several members of the company’s executive leadership team, including:
- Maureen Ladouceur, EVP and Chief Commercial Officer
- Andy Augustine, Chief Technology Officer
- Tom Halliday, General Manager, Strategic Intelligence
- Moderated by Barnaby Pickering, Managing Editor, Custom Content
